2,421 results
P
breast lesions
I/C
combined shear-wave elastography (SWE) and B-mode ultrasonography (US), B-mode US alone
O
diagnostic performance, biopsy reduction rate, area under the receiver operating characteristic curve (AUC)
P
Oral anticoagulants (OAC), P-glycoprotein (P-gp)/CYP3A4 enzyme
I/C
P-gp/CYP3A4 inhibitors, Rivaroxaban, Dabigatran, Apixaban, Edoxaban, Warfarin
O
Major bleeding, Gastrointestinal (GI) bleeding, Stroke/systemic embolism (SE), All-cause mortality, Any bleeding, Intracranial hemorrhage (ICH)
P
1200 participants
I/C
Acupuncture alone, Acupuncture combined with vitamin B, Vitamin B
O
Clinical efficacy
P
pollen, UV-B radiation
I/C
UV-B radiation, pollen germination and tube growth
O
substantial reduction in both pollen germination and tube growth
P
soil microbial extracellular hydrolytic enzymatic activities (Hy-EEAs), soil oxidative enzymatic activities (Ox-EEAs), soil carbon (C), soil nitrogen (N), soil phosphorus (P)
I/C
natural forest conversion (NFC), Changes in soil Hy- and Ox-EEAs, changes in soil organic C, available P, microbial biomass C and N
O
depletion of soil organic carbon, stimulated soil microbial secretion of Hy- and Ox-EEAs, soil total N scarcity, provoke soil microbial Hy-EEAs, soil total P dearth, quickened the soil Ox-EEAs, plenitude of soil available P, suppressed soil Hy- and Ox-EEAs
P
NAFLD participants, controls
I/C
fetuin-A, fetuin-B, compared with controls
O
strength of the association between fetuin-A, fetuin-B, and NAFLD
P
patients with large B cell lymphoma (LBCL)
I/C
bridging therapy (BT), CAR-T therapy
O
poorer overall survival, 1-year progression-free survival, complete response rate, and grade ≥3 immune effector cell-associated neurotoxicity syndrome
P
type B intramural hematoma (BIMH)
I/C
thoracic endovascular aortic repair (TEVAR), optimal medical treatment (OMT)
O
aortic-related death, regression/resolution, progression to dissection, secondary intervention, all-cause death
P
patients with heart failure with reduced ejection fraction (HFrEF)
I/C
treated with sacubitril/valsartan (Sac/Val) according to standard prescribing information
O
changes in B-type natriuretic peptide (BNP) concentrations
P
patients with chronic HBV infection
I/C
HBsAg seroclearance, HBsAg-persistent group
O
liver decompensation, HCC, liver transplantation, death